North Carolina has quickly become a leading hub for the manufacturing of GLP-1 weight loss drugs, including the new Wegovy pill that’s now on the market.
Why it matters: Having a pill form as opposed to a weekly shot is a big deal, largely because pills are cheaper to make than the widely popular injectables, NPR recently reported.
The big picture: One in eight U.S. adults take GLP-1 medications, around 32 million people, a recent KFF poll found.
- The transformation of GLP-1 drugs from niche to mainstream has been one of the most dramatic developments in health care this decade.
Yes, but: About 55% struggle to pay for them — with or without insurance — the poll also found…